734 related articles for article (PubMed ID: 1700618)
1. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
[TBL] [Abstract][Full Text] [Related]
2. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
[TBL] [Abstract][Full Text] [Related]
4. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
5. Structural distinctions among human breast epithelial cells revealed by the monclonal antikeratin antibodies AE1 and AE3.
Sorenson SC; Asch BB; Connolly JL; Burstein NA; Asch HL
J Pathol; 1987 Oct; 153(2):151-62. PubMed ID: 2447254
[TBL] [Abstract][Full Text] [Related]
6. Vimentin expression in benign and malignant lesions in the human mammary gland.
Wada T; Yasutomi M; Hashmura K; Kunikata M; Tanaka T; Mori M
Anticancer Res; 1992; 12(6B):1973-82. PubMed ID: 1284196
[TBL] [Abstract][Full Text] [Related]
7. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
[TBL] [Abstract][Full Text] [Related]
8. Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.
Holthöfer H; Miettinen A; Paasivuo R; Lehto VP; Linder E; Alfthan O; Virtanen I
Lab Invest; 1983 Sep; 49(3):317-26. PubMed ID: 6193332
[TBL] [Abstract][Full Text] [Related]
9. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
[TBL] [Abstract][Full Text] [Related]
10. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas.
Ivanyi D; Minke JM; Hageman C; Groeneveld E; van Doornewaard G; Misdorp W
Am J Vet Res; 1993 Jul; 54(7):1095-102. PubMed ID: 7690208
[TBL] [Abstract][Full Text] [Related]
12. A keratin epitope that is exposed in a subpopulation of preneoplastic and neoplastic mouse mammary epithelial cells but not in normal cells.
Asch BB; Asch HL
Cancer Res; 1986 Mar; 46(3):1255-62. PubMed ID: 2417702
[TBL] [Abstract][Full Text] [Related]
13. The intermediate filament complement of the spectrum of nerve sheath neoplasms.
Gould VE; Moll R; Moll I; Lee I; Schwechheimer K; Franke WW
Lab Invest; 1986 Oct; 55(4):463-74. PubMed ID: 3531717
[TBL] [Abstract][Full Text] [Related]
14. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
Pellegrino MB; Asch BB; Connolly JL; Asch HL
Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
[TBL] [Abstract][Full Text] [Related]
16. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin intermediate filament expression in benign and malignant breast disease.
Heatley M; Maxwell P; Whiteside C; Toner P
J Clin Pathol; 1995 Jan; 48(1):26-32. PubMed ID: 7535804
[TBL] [Abstract][Full Text] [Related]
18. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
[TBL] [Abstract][Full Text] [Related]
19. Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.
Gould VE; Jansson DS; Molenaar WM; Rorke LB; Trojanowski JQ; Lee VM; Packer RJ; Franke WW
Lab Invest; 1990 Apr; 62(4):498-509. PubMed ID: 2159086
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins.
Jarasch ED; Nagle RB; Kaufmann M; Maurer C; Böcker WJ
Hum Pathol; 1988 Mar; 19(3):276-89. PubMed ID: 2450059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]